News

Latest News

Stay up-to-date on Albemarle's latest advancements by reading our news releases, accessing images and videos and getting information on upcoming events.

Media Contacts:

Hailey Cobb
External Communications
Albemarle Corporation
4350 Congress Street
Suite 700
Charlotte, NC 28209
Phone: 980-299-5640
E-mail: hailey.cobb@albemarle.com

Dave Ryan
Chief Strategy Officer
Albemarle Corporation
4350 Congress Street
Suite 700
E-mail: invest@albemarle.com

Apr
23
2018

Albemarle Corporation to Present at Goldman Sachs Basic Materials Conference

CHARLOTTE, N.C. , April 23, 2018 /PRNewswire/ -- Albemarle Corporation (NYSE: ALB), a leader in the global specialty chemicals industry, announced today that Scott Tozier , Albemarle Executive Vice President and Chief Financial Officer, and Eric Norris , Chief Strategy Officer, will participate in
Read More
Apr
19
2018

Albemarle Declares Force Majeure Due to Shortage of Key Raw Materials in Urethane Supply Chain

CHARLOTTE, N.C. , April 19, 2018 /PRNewswire/ -- Albemarle Corporation (NYSE: ALB), a leader in the global specialty chemicals industry, announced today that it has declared force majeure due to the shortage of key raw materials in the production of diethyl toluene diamine (DETDA) curative
Read More

CPhI North America / InformEx

Philadelphia, PA
Apr 24 - 26, 2018


Venue: Pennsylvania Convention Center
Booth: 419

Learn More
Apr
18
2018

Albemarle Corporation to present at Barclays Electronic Chemicals Conference

CHARLOTTE, N.C. , April 18, 2018 /PRNewswire/ -- Albemarle Corporation (NYSE: ALB), a leader in the global specialty chemicals industry, announced today that Scott Tozier , Albemarle Executive Vice President and Chief Financial Officer, will present at the Barclays Electronic Chemicals Conference
Read More
Apr
16
2018

Albemarle Corporation Announces Appointment of Dr. Glen Merfeld, Chief Technology Officer for Lithium Business

CHARLOTTE, N.C. , April 16, 2018 /PRNewswire/ -- Albemarle Corporation (NYSE: ALB), a leader in the global specialty chemicals industry, announced today that it has named Dr. Glen Merfeld as Albemarle's Chief Technology Officer for its Lithium business, effective immediately.
Read More
Apr
09
2018

Albemarle Corporation to release first quarter 2018 earnings results on May 9, 2018

Conference call to be held on May 10, 2018 at 9:00 a.m. ET CHARLOTTE, N.C. , April 9, 2018 /PRNewswire/ -- Albemarle Corporation (NYSE: ALB), a leader in the global specialty chemicals industry, announced today that it will release its first quarter 2018 earnings after the NYSE closes on Wednesday,
Read More
Apr
03
2018

Albemarle completes sale of portion of Performance Catalysts Solutions to W. R. Grace & Co.

CHARLOTTE, N.C. , April 3, 2018 /PRNewswire/ --  Albemarle Corporation (NYSE: ALB), a leader in the global specialty chemicals industry, announced today the successful completion of the previously announced sale of its polyolefin catalysts and components business to W. R. Grace & Co.
Read More
Mar
09
2018

Albemarle Corporation Receives Increase in Lithium Quota for Chile Operations

CHARLOTTE, N.C. , March 9, 2018 /PRNewswire/ --  Albemarle Corporation  (NYSE: ALB), a leader in the production of lithium and lithium derivatives, announced today that as expected, it has received approval from Chile's Economic Development Agency (CORFO) for an increase in the company's lithium
Read More
Feb
28
2018

Q4 2017 Albemarle Corporation Earnings Conference Call

For Pre-Registration, please Click Here

US Toll free: 1 888 268.4181
International direct: +1 617 597.5486
Passcode: 954 695 20#

A replay of this call will be available for seven days at the following number:
US Toll free: 1 888 286.8010
International direct: +1 617 801.6888
Passcode: 44722105

Read More
Feb
27
2018

Albemarle finishes strong - guiding to continued growth in 2018

CHARLOTTE, N.C. , Feb. 27, 2018 /PRNewswire/ -- Fourth quarter 2017 highlights: Fourth quarter net sales were $857.8 million , an increase of 23% over the prior year Fourth quarter loss of $218.4 million , or $1.95 per diluted share, included $366.9 million of income tax expense related to the new
Read More
Page: